FORT WORTH, Texas, April 30, 2019 /PRNewswire/ — Galderma Laboratories, L.P., a global leader focused on meeting the world’s increasing skin health needs, proudly celebrates the 10-year FDA approval anniversary of Dysport(abobotulinumtoxinA) for Injection*. …